PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15037515-6	2004	In both behavioural (potentiation of 5-hydroxytryptophan (5-HTP)-induced behaviour) and electrophysiological studies (inhibition of 5-HT-elicited ion currents in Xenopus oocytes expressing the human SERT (hSERT) R-citalopram inhibited the effects of S-citalopram in a dose-dependent manner.	5-Hydroxytryptophan	58-63	solute carrier family 6 member 4	Homo sapiens	199-203	
27692695-5	2016	Adjunctive administration of 5-hydroxytryptophan (5-HTP) safely elevates 5-HTExt beyond the SERT inhibitor effect in humans; however, 5-HTP cannot be a clinically viable drug because of its poor pharmacokinetics.	5-Hydroxytryptophan	29-48	solute carrier family 6 member 4	Homo sapiens	92-96	
27692695-5	2016	Adjunctive administration of 5-hydroxytryptophan (5-HTP) safely elevates 5-HTExt beyond the SERT inhibitor effect in humans; however, 5-HTP cannot be a clinically viable drug because of its poor pharmacokinetics.	5-Hydroxytryptophan	50-55	solute carrier family 6 member 4	Homo sapiens	92-96	
15037515-6	2004	In both behavioural (potentiation of 5-hydroxytryptophan (5-HTP)-induced behaviour) and electrophysiological studies (inhibition of 5-HT-elicited ion currents in Xenopus oocytes expressing the human SERT (hSERT) R-citalopram inhibited the effects of S-citalopram in a dose-dependent manner.	5-Hydroxytryptophan	37-56	solute carrier family 6 member 4	Homo sapiens	199-203